Jefferies Upgrades Agilon Health to Buy, Raises Price Target to $48

Benzinga Newsdesk www.benzinga.com Positive 88.3%

Neg 0% Neu 0% Pos 88.3%

Jefferies analyst Jack Slevin upgrades Agilon Health (NYSE:AGL) from Hold to Buy and raises the price target from $27.5 to $48.